In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential based on recent research conducted by ZS on the top 25 pharma companies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: David Jackson
All content for Inside Global Pharma is the property of ZS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential based on recent research conducted by ZS on the top 25 pharma companies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: David Jackson
Cancer has been progressively redefined over the past 20 years. One of the most active pipelines is immunotherapy, with almost 300 molecules in phase one or phase two trials. In this episode we are discussing if existing immunotherapies have lived up to the expectations and what will drive success for the next wave of products in this evolving market.
Hosted by: Jennifer Curtis
Produced by: Matilda Males and Rohan Giblin
Featuring: Malik Kaman, Jon Roffman, Sharon Karlsberg
Inside Global Pharma
In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential based on recent research conducted by ZS on the top 25 pharma companies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: David Jackson
